Using Western Blotting methods, Chabot et al (1996) showed the presence of CYP3A4 in all 10 tested breast cancer samples, while Forrester et al (1990), Albin et al (1993) and Hellmold et al (1998) described negative results. This evidence concerns the gene CYP3A4 and breast carcinoma.